RxDoctor Payments Data

Ricardo Yamada, MD

Vascular & Interventional Radiology · Charleston, SCNPI 1194012914

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Terumo Medical Corporation at 54.8% of the total. Reporting peaked in 2024 at $28,744 and has fallen 59.4% since, to $11,671 in 2025. Among vascular & interventional radiology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,817in general payments, 2019–2025

Across 128 payments — averaging $568.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Medical Corporation$40K
  • Inari Medical, Inc.$27K
  • Guerbet LLC$3K
  • Medtronic$981
  • Boston Scientific$528
  • Penumbra, Inc.$435
  • plus $648 from 3 others
$71,831in research payments, 2019–2025

Across 4 payments — averaging $17,958 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Terumo Medical Corporation$72K

What the payments were for

  • Consulting fees$40,13055%
  • Speaking & faculty fees$13,75019%
  • Travel & lodging$13,45118%
  • Food & beverage$5,4868%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,817 in reported general payments places this provider in the 95th percentile of 61 vascular & interventional radiology providers in South Carolina.

See all vascular & interventional radiology providers in South Carolina

Medicare billing

Part B allowed, 2024
$69,754
Medicare patients
265
Services billed
1,825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →